Navigation Links
Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula

IRVINE, Calif., May 10, 2011 /PRNewswire/ -- Cobalis Corp. (CLSC.PK) announced today they have started airing 60-second television commercials for PreHistin® Allergy Defense Formula, on major national cable and satellite networks across the US.

The commercials, featuring leading US allergist Dr. Paul H. Ratner, MD, explain how PreHistin works at the root cause of allergies, giving seasonal and year-round sufferers the first truly new advance in allergies in many years -- a safe and effective, side-effect free, all natural product intended, in the words of Dr. Ratner, to "help restore a normal response to seasonal and year-round allergies, which is no allergic response at all!"

The commercials were created to help build the PreHistin brand to consumers and allergy sufferers, and drive traffic to the pharmacy retailers across the US who now carry PreHistin in their allergy section. The commercials are now being placed on national cable networks and satellite cable providers, in a planned $5 million TV advertising campaign reaching a daily audience of over 300 million Americans, such as ION, Reelz, Great American Country, Style, Cooking Channel, ABC Family, BBC, BIO, OWN, E!, Lifetime, Oxygen, Soapnet, Womens' Entertainment, Style and many others.

The spots not only present the PreHistin story and explain the real cause of allergies, but prompt viewers that PreHistin is available now at fine pharmacies everywhere, and to "ask your pharmacist for PreHistin today."

Marty Marion, Cobalis CEO said, "We are excited to announce the start of our national TV campaign for PreHistin, which was selected as "Best New Product of 2011" out of a field of over a thousand products at the recent ECRM Cough, Cold and Allergy show. We are committed to supporting those retailers and pharmacies who are selling PreHistin, and television is just one of the support channels we are engaging to drive traffic, stimulate brand awareness and increase sales."

Cobalis President Chas Radovich said, "We believe that when allergy sufferers learn the PreHistin story they will try PreHistin for its ability to naturally restore a normal non-reactive response to allergens with no side effects or sedation. We thank the retailers who have brought PreHistin into their stores, and who are partnering with us to build PreHistin into a national brand."

PreHistin is now on shelves at one of the nation's two largest drugstore chains, as well as many fine regional and local pharmacies, and is expected to be on the shelf at most pharmacy and grocery shelves across the country very quickly.


PreHistin® Allergy Defense Formula is a patented cobalamin complex that helps rebalance the immune system to lower allergen antibody IgE levels, and regulate the release of symptom-linked histamine. PreHistin is a cherry-flavored lozenge dissolved under the tongue and then swallowed twice a day, usually starting before the allergy season, or taken daily for those suffering from year-round allergies. PreHistin has no known side effects, is 100% non-drowsy, and has no contraindications with any other medications. In clinical trials on thousands of allergy sufferers, PreHistin was shown to be safe and effective in reducing nasal symptoms.


Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, "The World's First Pre-Histamine", is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin is now available without prescription for both long-term and daily use.

For PreHistin product information please visit or call toll free 1-877-4POLLEN (1-877-476-5536). For additional company information please visit the corporate website at


Cobalis Corp.
16795 Von Karman, Suite 200
Irvine, CA 92606
949-260-0123 (pacific time)

Chas Radovich, President
Martin Marion, CEO

SOURCE Cobalis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cobalis Corp. Receives $415,000 First Purchase Order from Major Retail Pharmacy for PreHistin® Allergy Defense Formula
2. Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010
3. Cobalis Corp. Provides Marketing Update Conference Call for Investors
4. BAETA Corp. Expands Market Awareness Programs
5. ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011
6. Immune Design Corp. Appoints Pharma and Biotech Executive Carlos V. Paya, MD, PhD as Chief Executive Officer
7. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
8. BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytrens Contracture in Europe
9. Cantel Medical Corp. to Present at the Needham & Company 10th Annual Healthcare Conference
10. NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
11. NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002
Post Your Comments:
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
Breaking Medicine News(10 mins):